| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Pacira Biosciences, Inc. (PCRX) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. PCRX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 399.0K | $9.20M | - | |
| Other | 218.9K | $5.05M | - | |
| Other | 167.1K | $3.85M | -10,259 | |
| CFO | 118.3K | $2.73M | - | |
| VP | 62.3K | $1.44M | -6,115 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 6, 2021 | Reinhardt Max79 | President | Sell | 110 | $60.81 | $6,689.10 | -0.8% | |
| Nov 16, 2020 | Brege Laura62 | Director | Sale+OE | 12,000 | $65.95 | $791,400.00 | -60.2% | |
| Nov 13, 2020 | Reinhardt Max79 | President | Sale+OE | 25,000 | $63.38 | $1,584,390.00 | -33.8% | |
| Nov 13, 2020 | Riker Lauren Bullaro76 | Vice President, Finance | Sale+OE | 3,000 | $63.81 | $191,430.00 | -18.5% | |
| Nov 13, 2020 | Winston Roy68 | Chief Clinical Officer | Sell | 5,000 | $62.00 | $310,000.00 | -12.6% | |
| Oct 16, 2020 | Stack David M67 | CEO And Chairman | Sale+OE | 90,000 | $55.36 | $4,982,700.00 | -14.8% | |
| Sep 17, 2020 | Reinhardt Max79 | President | Sale+OE | 25,420 | $59.81 | $1,520,317.88 | -45.1% | |
| Sep 17, 2020 | Williams Kristen Marie76 | Chief Administrative Officer | Sale+OE | 83,577 | $59.78 | $4,996,498.07 | -30.9% | |
| Sep 16, 2020 | Riker Lauren Bullaro76 | Vice President, Finance | Sale+OE | 3,000 | $60.34 | $181,020.00 | -18.5% | |
| Sep 9, 2020 | Wicki Andreas71 | Director | Sell | 2,216 | $62.02 | $137,436.32 | -0.3% |